Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Addiction. 2011 Aug 18;106(11):2039–2046. doi: 10.1111/j.1360-0443.2011.03519.x

Table 4.

The elaborated ME model1 for predicting daily quit probability (n=540).

Predictor2 OR 95% CI P value
Sex: female 0.63 (0.48, 0.82) 0.0008
FTND score: ≥6 0.58 (0.44, 0.76) <0.0001
CESD: ≥16 0.73 (0.54, 0.98) 0.0340
Previous day smoking status 0.35 (0.33, 0.38) <0.0001
Number of smoking days in the last week 0.76 (0.74, 0.77) <0.0001
Week1 vs. week8 2.37 (1.98, 2.84) <0.0001
Week2 vs. week8 1.44 (1.19, 1.75) 0.0002
Week3 vs. week8 1.19 (0.98, 1.45) 0.0782
Week4 vs. week8 1.20 (0.98, 1.46) 0.0770
Week5 vs. week8 1.05 (0.86, 1.29) 0.6169
Week6 vs. week8 0.92 (0.75, 1.12) 0.4085
Week7 vs. week8 0.99 (0.81, 1.22) 0.9606
Bupropion in week1 2.04 (1.52, 2.74) <0.0001
Bupropion in week2 1.81 (1.32, 2.47) 0.0002
Bupropion in week3 2.64 (1.92, 3.63) <0.0001
Bupropion in week4 2.29 (1.65, 3.17) <0.0001
Bupropion in week5 1.94 (1.41, 2.69) <0.0001
Bupropion in week6 2.27 (1.64, 3.15) <0.0001
Bupropion in week7 1.75 (1.26, 2.44) 0.0010
Bupropion in week8 1.91 (1.37, 2.67) 0.0002

Notes:

1

The estimated variance of the random effect in the ME model was 5.51; estimates and CIs were adjusted by the scale factor (see Table 2).

2

Analysis adjusted for other baseline factors: race and site.